Qmiiz Odt is owned by Tersera.
Qmiiz Odt contains Meloxicam.
Qmiiz Odt has a total of 1 drug patent out of which 0 drug patents have expired.
Qmiiz Odt was authorised for market use on 19 October, 2018.
Qmiiz Odt is available in tablet, orally disintegrating;oral dosage forms.
The generics of Qmiiz Odt are possible to be released after 31 August, 2030.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US8545879||TERSERA||Fast disintegrating compositions of meloxicam|| |
(7 years from now)
Drugs and Companies using MELOXICAM ingredient
Market Authorisation Date: 19 October, 2018
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic